← ANALYST RATINGS · TIPRANKS
RxSight (RXST): analyst forecast and price target
Analyst consensus
Hold0 Buy4 Hold1 Sell
Ratings of 5 analysts in the last 3 months · top analysts only12-month forecast
Based on 5 price targets given in the last 3 months, the average target is $8.00, the highest $10.00, the lowest $6.00. The average is +77.4% from the last price of $4.51.
Analyst ratings 10
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 15.10.26on TipRanks 05:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 13.10.26on TipRanks 07:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 13.10.26on TipRanks 07:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 13.10.26on TipRanks 07:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $4.50 → $5.00+11.1% | Hold | +10.9% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $4.50 → $5.00+11.1% | Hold | +10.9% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $4.50 → $5.00+11.1% | Hold | +10.9% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $4.50 → $5.00+11.1% | Hold | +10.9% | Reiterated | 09.10.26on TipRanks 05:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 07.10.26on TipRanks 05:06 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $5.00 → $4.50−10.0% | Hold | −0.2% | Reiterated | 03.10.26on TipRanks 05:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $4.50 → $5.00+11.1% | Hold | +10.9% | Reiterated | 01.10.26on TipRanks 05:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $4.50 → $5.00+11.1% | Hold | +10.9% | Reiterated | 01.10.26on TipRanks 05:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $4.50 → $5.00+11.1% | Hold | +10.9% | Reiterated | 01.10.26on TipRanks 05:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $5.00 | Hold | +10.9% | Reiterated | 29.09.26on TipRanks 06:05 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $4.50 | Hold | −0.2% | Reiterated | 29.09.26on TipRanks 06:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $4.50 | Hold | −0.2% | Reiterated | 29.09.26on TipRanks 06:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $4.50 | Hold | −0.2% | Reiterated | 29.09.26on TipRanks 06:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $5.00 | Hold | +10.9% | Reiterated | 29.09.26on TipRanks 06:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $5.00 | Hold | +10.9% | Reiterated | 29.09.26on TipRanks 06:05 | — | |
| Young Li★★★★★★★★★★#12189 · hits 16% · avg −26.1% | Jefferies | $6.50 → $5.75−11.5% | Hold | +27.5% | Reiterated | 22.09.26on TipRanks 08:35 | −4.1%next day −0.9% · 5 days −2.1% | ↗ |
| Stephanie Elghazi★★★★★★★★★★#8552 · hits 50% · avg +2.3% | Bank of America Securities | $6.50 → $5.50−15.4% | Sell | +22.0% | Reiterated | 22.09.26on TipRanks 06:30 | −4.1%next day −0.9% · 5 days −2.1% | ↗ |
| Thomas Stephan★★★★★★★★★★#3049 · hits 47% · avg +8.4% | Stifel Nicolaus | $8.00 → $7.00−12.5% | Hold | +55.2% | Reiterated | 10.08.26on TipRanks 07:01 | +5.0%next day +7.5% · 5 days −1.3% | ↗ |
| Steven Lichtman★★★★★★★★★★#568 · hits 54% · avg +14.7% | William Blair | — | Hold | — | Reiterated | 07.08.26on TipRanks 14:10 | +2.4%next day +5.0% · 5 days +9.7% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $6.00 | Sell | +33.0% | Reiterated | 06.08.26on TipRanks Aug 7 08:10 | −3.2%next day +2.4% · 5 days +14.1% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $5.50 → $6.30+14.5% | Hold | +39.7% | Reiterated | 06.08.26on TipRanks 08:50 | −3.2%next day +2.4% · 5 days +14.1% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $9.00 | Hold | +99.6% | Reiterated | 06.08.26on TipRanks 07:15 | −3.2%next day +2.4% · 5 days +14.1% | ↗ |
| Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% | Piper Sandler | $10.00 | Hold | +121.7% | Reiterated | 06.08.26on TipRanks 07:01 | −3.2%next day +2.4% · 5 days +14.1% | ↗ |
| Ryan Zimmerman★★★★★★★★★★#3375 · hits 46% · avg +3.3% | BTIG | — | Hold | — | Reiterated | 06.08.26on TipRanks 06:05 | −3.2%next day +2.4% · 5 days +14.1% | ↗ |
| David Saxon★★★★★★★★★★#6662 · hits 38% · avg +0.8% | Needham | $11.00 | Buy | +143.9% | Reiterated | 06.08.26on TipRanks 02:55 | −3.2%next day +2.4% · 5 days +14.1% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering RxSight
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $7.57 at a price of $4.90 (+54.5%); now: $7.57 at $4.51 (+67.8%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 3 | 5 | 6 | 6 | 4 |
| Sell | 1 | 1 | 2 | 3 | 3 | 2 |
Earnings and sales forecast
Next report: 11.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.31 (from $-0.49 to $-0.10). Last quarter: $-0.29.
Sales
Next quarter’s sales estimate — $27M (from $25M to $29M). Last quarter: $34M.
Best top-analyst consensus in the sector · Healthcare
About RxSight
- CEO: Aziz Mottiwala
- Employees: 461
- 100 Columbia, Aliso Viejo, CA, 92656, US
- www.rxsight.com
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Data from the stock’s TipRanks forecast page, read 73 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗